Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for…
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…
New collaboration delivers confidential and convenient telehealth services to address erectile dysfunction for men DALLAS, Dec. 11, 2024 /PRNewswire/ --…
CHICAGO, Dec. 11, 2024 /PRNewswire/ -- Aon plc (NYSE: AON) reports that more U.S. hospitals are reporting steady or lower employee…
DALLAS, Dec. 11, 2024 /PRNewswire/ -- Every Black Life Matters (EBLM) supports the jury's not guilty verdict for Daniel Penny,…
Data Shows Pomelo's Virtual Care Model Reduces Total Cost of Maternal Care in Medicaid Population, Lowers NICU and ER Utilization for…
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for…
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is…
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose…
MORRISTOWN, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment…